Adastra Holdings (CNSX:XTRX) - Aandelenkoers, Nieuws & Analyse

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

XTRX Overzicht aandelen

Adastra Holdings Ltd. onttrekt en verwerkt cannabis voor recreatieve en medische markten in Canada.

XTRX fundamentele analyse
Sneeuwvlok Score
Waardering	2/6
Toekomstige groei	0/6
Prestaties in het verleden	0/6
Financiële gezondheid	4/6
Dividenden	0/6

Beloningen

Earnings have grown 5.4% per year over the past 5 years

Risicoanalyse

Highly volatile share price over the past 3 months

Has less than 1 year of cash runway

Does not have a meaningful market cap (CA$6M)

Adastra Holdings Ltd. Concurrenten

Valeo Pharma

TSX:VPH

CA$4.4m

Christina Lake Cannabis

CNSX:CLC

CA$4.6m

Ayurcann Holdings

CNSX:AYUR

CA$7.8m

CanadaBis Capital

TSXV:CANB

CA$8.3m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Adastra Holdings
Historische aandelenkoersen
Huidige aandelenkoers	CA$0.095
52 Week Hoogtepunt	CA$0.30
52 Week Laag	CA$0.05
Bèta	-0.38
11 maand verandering	5.56%
3 maanden verandering	-17.39%
1 Jaar Verandering	-62.00%
33 jaar verandering	-91.95%
5 jaar verandering	n/a
Verandering sinds IPO	-93.40%

Recent nieuws en updates

Market Cool On Adastra Holdings Ltd.'s (CSE:XTRX) Revenues Pushing Shares 26% Lower

Sep 08

Is Adastra Holdings (CSE:XTRX) A Risky Investment?

Sep 04

Adastra Holdings Ltd. (CSE:XTRX) Might Not Be As Mispriced As It Looks After Plunging 41%

Jul 11

Recent updates

Market Cool On Adastra Holdings Ltd.'s (CSE:XTRX) Revenues Pushing Shares 26% Lower

Sep 08

Is Adastra Holdings (CSE:XTRX) A Risky Investment?

Sep 04

Adastra Holdings Ltd. (CSE:XTRX) Might Not Be As Mispriced As It Looks After Plunging 41%

Jul 11

Adastra Holdings Ltd. (CSE:XTRX) Might Not Be As Mispriced As It Looks After Plunging 27%

May 08

Adastra Holdings Ltd.'s (CSE:XTRX) Shares Leap 26% Yet They're Still Not Telling The Full Story

Mar 08

Rendement voor aandeelhouders

	XTRX	CA Pharmaceuticals	CA Markt
7D	5.6%	-1.8%	0.4%
1Y	-62.0%	-6.7%	24.6%

Rendement versus industrie: XTRX underperformed the Canadian Pharmaceuticals industry which returned -9.8% over the past year.

Rendement versus markt: XTRX underperformed the Canadian Market which returned 23.2% over the past year.

Prijsvolatiliteit

Is XTRX's price volatile compared to industry and market?
XTRX volatility
XTRX Average Weekly Movement	33.7%
Pharmaceuticals Industry Average Movement	10.4%
Market Average Movement	8.3%
10% most volatile stocks in CA Market	17.1%
10% least volatile stocks in CA Market	3.0%

Stabiele aandelenkoers: XTRX's share price has been volatile over the past 3 months.

Volatiliteit in de loop van de tijd: XTRX's weekly volatility has increased from 23% to 34% over the past year.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
n/a	n/a	n/a	adastraholdings.ca

Adastra Holdings Ltd. onttrekt en verwerkt cannabis voor recreatieve en medische markten in Canada. Het bedrijf biedt vape-pennen, wax, hars, geïnfuseerde pre-rolls, diamanten en shatters aan onder de merknaam Endgame. Het bedrijf biedt ook advies, white label-productie en tolling-diensten; en geeft licenties op zijn intellectuele eigendom voor de verkoop van verpakte goederen voor consumenten.

Adastra Holdings Ltd. Samenvatting

Hoe verhouden de winst en inkomsten van Adastra Holdings zich tot de beurswaarde?
XTRX fundamentele statistieken
Marktkapitalisatie	CA$5.60m
Inkomsten(TTM)	-CA$3.36m
Inkomsten(TTM)	CA$22.75m

0.2x

P/S-verhouding

-1.6x

Koers/Winstverhouding

Is XTRX overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
XTRX resultatenrekening (TTM)
Inkomsten	CA$22.75m
Kosten van inkomsten	CA$14.56m
Brutowinst	CA$8.19m
Overige uitgaven	CA$11.55m
Inkomsten	-CA$3.36m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	-0.06
Brutomarge	36.00%
Nettowinstmarge	-14.78%
Schuld/Eigen Vermogen Verhouding	26.4%

Hoe presteerde XTRX op de lange termijn?

Bekijk historische prestaties en vergelijking

XTRX Overzicht aandelen

Beloningen

Risicoanalyse

Adastra Holdings Ltd. Concurrenten

TSX:VPH

CA$4.4m

CNSX:CLC

CA$4.6m

CNSX:AYUR

CA$7.8m

TSXV:CANB

CA$8.3m

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Lachlan Mcleod Resigns as Chief Financial Officer of Adastra Holdings Ltd

Market Cool On Adastra Holdings Ltd.'s (CSE:XTRX) Revenues Pushing Shares 26% Lower

Is Adastra Holdings (CSE:XTRX) A Risky Investment?

Second quarter 2024 earnings released: EPS: CA$0.001 (vs CA$0.019 loss in 2Q 2023)

Adastra Holdings Ltd. (CSE:XTRX) Might Not Be As Mispriced As It Looks After Plunging 41%

First quarter 2024 earnings released: CA$0.023 loss per share (vs CA$0.006 loss in 1Q 2023)

Recent updates

Lachlan Mcleod Resigns as Chief Financial Officer of Adastra Holdings Ltd

Market Cool On Adastra Holdings Ltd.'s (CSE:XTRX) Revenues Pushing Shares 26% Lower

Is Adastra Holdings (CSE:XTRX) A Risky Investment?

Second quarter 2024 earnings released: EPS: CA$0.001 (vs CA$0.019 loss in 2Q 2023)

Adastra Holdings Ltd. (CSE:XTRX) Might Not Be As Mispriced As It Looks After Plunging 41%

First quarter 2024 earnings released: CA$0.023 loss per share (vs CA$0.006 loss in 1Q 2023)

Adastra Holdings Ltd. (CSE:XTRX) Might Not Be As Mispriced As It Looks After Plunging 27%

Adastra Holdings Files Form 15

Full year 2023 earnings released: CA$0.063 loss per share (vs CA$0.072 loss in FY 2022)

Less than half of directors are independent

Adastra Holdings Ltd. Announces Resignation of Smoke Wallin from Its Board of Directors

Adastra Holdings Announces Executive Changes

High number of new directors

Adastra Holdings Ltd.'s (CSE:XTRX) Shares Leap 26% Yet They're Still Not Telling The Full Story

Adastra Holdings Ltd.'s (CSE:XTRX) Shares Not Telling The Full Story

Third quarter 2023 earnings released: CA$0.011 loss per share (vs CA$0.008 loss in 3Q 2022)

Here's Why Adastra Holdings (CSE:XTRX) Can Afford Some Debt

Second quarter 2023 earnings released: CA$0.019 loss per share (vs CA$0.008 loss in 2Q 2022)

Subdued Growth No Barrier To Adastra Holdings Ltd.'s (CSE:XTRX) Price

Adastra Holdings Ltd., Annual General Meeting, Sep 14, 2023

Full year 2022 earnings released: CA$0.072 loss per share (vs CA$0.055 loss in FY 2021)

Adastra Holdings Ltd. Announces Executive Changes

Does Adastra Holdings (CSE:XTRX) Have A Healthy Balance Sheet?

Third quarter 2022 earnings released: CA$0.008 loss per share (vs CA$0.005 loss in 3Q 2021)

High number of new and inexperienced directors

We Think Adastra Holdings (CSE:XTRX) Has A Fair Chunk Of Debt

Adastra Holdings Ltd. Receives Controlled Substances Dealer's License

Second quarter 2022 earnings released: CA$0.008 loss per share (vs CA$0.012 loss in 2Q 2021)

Adastra Holdings Ltd. Receives Its Medical Sales License from Health Canada

High number of new and inexperienced directors

Adastra Holdings Ltd. Announces the Appointment of Smoke Wallin to the Company's Board of Directors

Adastra Holdings Ltd. announced delayed 20-F filing

High number of new and inexperienced directors

Adastra Holdings Ltd., Annual General Meeting, Jun 23, 2022

Adastra Announces Successful Soft Launch of Endgame Brand in BC

Adastra Holdings Ltd. Announces Executive Changes

Does Adastra Holdings (CSE:XTRX) Have A Healthy Balance Sheet?

Here's Why Adastra Holdings (CSE:XTRX) Can Afford Some Debt

High number of new and inexperienced directors

President recently bought CA$1.1m worth of stock

Here's Why Phyto Extractions (CSE:XTRX) Can Afford Some Debt

Phyto Extractions Inc. Officially Launches Shatter for Adult-Use Market

Auditors Have Doubts About Phyto Extractions (CSE:XTRX)

Adastra Labs Holdings Ltd. announced a financing transaction

Adastra Labs Holdings (2019) Ltd. Announces Executive Changes

New 90-day low: CA$0.33

Adastra Labs Holdings (CSE:XTRX) Is Making Moderate Use Of Debt

New 90-day low: CA$0.48

Adastra Labs Holdings Ltd. Commences Full-Scale Cryo-Ethanol Extraction Operations

New 90-day low: CA$0.67

Adastra Labs Holdings Ltd. Announces the Completion of Installation and Start of Commissioning of its Cryo-Ethanol Extraction System from Evolved Extraction Solutions

New 90-day high: CA$0.98

New 90-day high - CA$0.91

Adastra Labs Holdings Ltd. announced that it has received CAD 3.4944 million in funding

Adastra Labs Holdings Ltd. to Report Second Half, 2020 Results on Jul 14, 2020

Rendement voor aandeelhouders

Prijsvolatiliteit

Over het bedrijf

Adastra Holdings Ltd. Samenvatting